Jerome Canady

US Medical Innovations (USMI), founded by Dr. Jerome Canady, is a private biomedical device and biotechnology company focused on the development of advanced plasma-based surgical technologies. The company's flagship technology, the Canady Helios Cold Atmospheric Plasma (CAP) system, is designed to selectively target and kill cancer cells while sparing healthy tissue during surgical procedures. USMI operates in conjunction with the Jerome Canady Research Institute for Advanced and Molecular Medicine (JCRI-AMM) to integrate molecular biology and plasma physics into clinical oncology. Their product portfolio includes electrosurgical generators, robotic surgical attachments, and plasma-based scalpels aimed at reducing cancer recurrence and improving surgical outcomes.